United Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. 

CEO
Martine A. Rothblatt
CEOMartine A. Rothblatt
Employees
1,400
Employees1,400
Headquarters
Silver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded
1996
Founded1996
Employees
1,400
Employees1,400

UTHR Key Statistics

Market cap
21.38B
Market cap21.38B
Price-Earnings ratio
17.90
Price-Earnings ratio17.90
Dividend yield
Dividend yield
Average volume
726.97K
Average volume726.97K
High today
High today
Low today
Low today
Open price
$499.89
Open price$499.89
Volume
0.00
Volume0.00
52 Week high
$609.35
52 Week high$609.35
52 Week low
$397.97
52 Week low$397.97

Stock Snapshot

United Therapeutics(UTHR) stock is priced at $498.48, giving the company a market capitalization of 21.38B. It carries a P/E multiple of 17.90.

On 2026-09-17, United Therapeutics(UTHR) stock opened at $499.89, reached a high of —, and a low of —.

The United Therapeutics(UTHR)'s current trading volume is 0, compared to an average daily volume of 726.97K.

During the past year, United Therapeutics(UTHR) stock moved between $397.97 at its lowest and $609.35 at its peak.

During the past year, United Therapeutics(UTHR) stock moved between $397.97 at its lowest and $609.35 at its peak.

UTHR News

Investing.com 3d
United Therapeutics at Morgan Stanley conference: fibrosis push deepens - Investing.com

...

United Therapeutics at Morgan Stanley conference: fibrosis push deepens - Investing.com

Analyst ratings

81%

of 16 ratings
Buy
81.3%
Hold
18.8%
Sell
0%

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.